Cancer-causing mutations predict clotting risk. A set of oncogenic mutations has been identified3 to predict the risk of thrombosis in cancer patients. The outstanding challenge is to uncover the mechanisms whereby these mutant cancer genes project their influence systemically, as shown by the "?" in the figure.